The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review

Estrogen Replacement Therapy

Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Estrogen Replacement Therapy


Psychiatry related information on Estrogen Replacement Therapy


High impact information on Estrogen Replacement Therapy


Chemical compound and disease context of Estrogen Replacement Therapy


Biological context of Estrogen Replacement Therapy


Anatomical context of Estrogen Replacement Therapy


Associations of Estrogen Replacement Therapy with chemical compounds


Gene context of Estrogen Replacement Therapy


Analytical, diagnostic and therapeutic context of Estrogen Replacement Therapy


  1. The risk of breast cancer in postmenopausal women who have used estrogen replacement therapy. Wingo, P.A., Layde, P.M., Lee, N.C., Rubin, G., Ory, H.W. JAMA (1987) [Pubmed]
  2. Estrogen-progestin replacement therapy and endometrial cancer. Pike, M.C., Peters, R.K., Cozen, W., Probst-Hensch, N.M., Felix, J.C., Wan, P.C., Mack, T.M. J. Natl. Cancer Inst. (1997) [Pubmed]
  3. Estrogen deprivation and replacement modulate cerebral capillary density with vascular expression of angiogenic molecules in middle-aged female rats. Jesmin, S., Hattori, Y., Sakuma, I., Liu, M.Y., Mowa, C.N., Kitabatake, A. J. Cereb. Blood Flow Metab. (2003) [Pubmed]
  4. Effects of long-term estrogen replacement therapy on articular cartilage IGFBP-2, IGFBP-3, collagen and proteoglycan levels in ovariectomized cynomolgus monkeys. Ham, K.D., Oegema, T.R., Loeser, R.F., Carlson, C.S. Osteoarthr. Cartil. (2004) [Pubmed]
  5. Management of osteoporosis. An overview. Castelo-Branco, C. Drugs & aging. (1998) [Pubmed]
  6. Effects of estrogen replacement therapy on PET cerebral blood flow and neuropsychological performance. Resnick, S.M., Maki, P.M., Golski, S., Kraut, M.A., Zonderman, A.B. Hormones and behavior. (1998) [Pubmed]
  7. Inflammatory biomarkers, hormone replacement therapy, and incident coronary heart disease: prospective analysis from the Women's Health Initiative observational study. Pradhan, A.D., Manson, J.E., Rossouw, J.E., Siscovick, D.S., Mouton, C.P., Rifai, N., Wallace, R.B., Jackson, R.D., Pettinger, M.B., Ridker, P.M. JAMA (2002) [Pubmed]
  8. Tamoxifen therapy for breast cancer and endometrial cancer risk. Bernstein, L., Deapen, D., Cerhan, J.R., Schwartz, S.M., Liff, J., McGann-Maloney, E., Perlman, J.A., Ford, L. J. Natl. Cancer Inst. (1999) [Pubmed]
  9. Effects of mild asymptomatic primary hyperparathyroidism on bone mass in women with and without estrogen replacement therapy. McDermott, M.T., Perloff, J.J., Kidd, G.S. J. Bone Miner. Res. (1994) [Pubmed]
  10. Prevalence of menopausal symptoms among women with a history of breast cancer and attitudes toward estrogen replacement therapy. Couzi, R.J., Helzlsouer, K.J., Fetting, J.H. J. Clin. Oncol. (1995) [Pubmed]
  11. Effects of receptor tyrosine kinase inhibitor A47 on estrogen and growth factor-dependent breast cancer cell proliferation and apoptosis in vitro. Turbov, J.M., Twaddle, G.M., Yang, X., Liu, N.M., Murthy, S. Journal of surgical oncology. (2002) [Pubmed]
  12. Role of progesterone antagonists and new selective progesterone receptor modulators in reproductive health. Olive, D.L. Obstetrical & gynecological survey. (2002) [Pubmed]
  13. Biochemical bone markers and bone mineral density during postmenopausal hormone replacement therapy with and without vitamin D3: a prospective, controlled, randomized study. Heikkinen, A.M., Parviainen, M., Niskanen, L., Komulainen, M., Tuppurainen, M.T., Kröger, H., Saarikoski, S. J. Clin. Endocrinol. Metab. (1997) [Pubmed]
  14. Estrogen replacement therapy, serum lipids, and polymorphism of the apolipoprotein E gene. Garry, P.J., Baumgartner, R.N., Brodie, S.G., Montoya, G.D., Liang, H.C., Lindeman, R.D., Williams, T.M. Clin. Chem. (1999) [Pubmed]
  15. Adrenomedullin expression in rat uterus is correlated with plasma estradiol. Cameron, V.A., Autelitano, D.J., Evans, J.J., Ellmers, L.J., Espiner, E.A., Nicholls, M.G., Richards, A.M. Am. J. Physiol. Endocrinol. Metab. (2002) [Pubmed]
  16. Atrial natriuretic peptide, plasma renin activity, and aldosterone in women on estrogen therapy and with premenstrual syndrome. Davidson, B.J., Rea, C.D., Valenzuela, G.J. Fertil. Steril. (1988) [Pubmed]
  17. Urinary excretion of prostacyclin and thromboxane metabolites in climacteric women: effect of estrogen-progestin replacement therapy. Ylikorkala, O., Hirvonen, E., Saure, A., Viinikka, L. Prostaglandins (1990) [Pubmed]
  18. Comparison between 1 year oral and transdermal oestradiol and sequential norethisterone acetate on circulating concentrations of leptin in postmenopausal women. Laivuori, H., Koistinen, H.A., Karonen, S.L., Cacciatore, B., Ylikorkala, O. Hum. Reprod. (2001) [Pubmed]
  19. Estrogen restores cognition and cholinergic phenotype in an animal model of Down syndrome. Granholm, A.C., Ford, K.A., Hyde, L.A., Bimonte, H.A., Hunter, C.L., Nelson, M., Albeck, D., Sanders, L.A., Mufson, E.J., Crnic, L.S. Physiol. Behav. (2002) [Pubmed]
  20. Treatment of the vertebral crush fracture syndrome with enteric-coated sodium fluoride tablets and calcium supplements. Nagant de Deuxchaisnes, C., Devogelaer, J.P., Depresseux, G., Malghem, J., Maldague, B. J. Bone Miner. Res. (1990) [Pubmed]
  21. Effects of mammalian and plant estrogens on mammary glands and uteri of macaques. Foth, D., Cline, J.M. Am. J. Clin. Nutr. (1998) [Pubmed]
  22. Steroid hormone receptors and coregulators in endocrine-resistant and estrogen-independent breast cancer cells. Sarvilinna, N., Eronen, H., Miettinen, S., Vienonen, A., Ylikomi, T. Int. J. Cancer (2006) [Pubmed]
  23. Estradiol and the addition of progesterone increase the sensitivity to a neurosteroid in postmenopausal women. Wihlbäck, A.C., Nyberg, S., Bäckström, T., Bixo, M., Sundström-Poromaa, I. Psychoneuroendocrinology (2005) [Pubmed]
  24. Effects of oral and transdermal 17 beta-estradiol combined with progesterone on homocysteine metabolism in postmenopausal women: a randomised placebo-controlled trial. Lacut, K., Oger, E., Abalain, J.H., Moineau, M.P., Mottier, D. Atherosclerosis (2004) [Pubmed]
  25. Differential effects of oral and transdermal postmenopausal estrogen replacement therapies on C-reactive protein. Lacut, K., Oger, E., Le Gal, G., Blouch, M.T., Abgrall, J.F., Kerlan, V., Scarabin, P.Y., Mottier, D. Thromb. Haemost. (2003) [Pubmed]
  26. Growth hormone secretion in premenopausal women before and after ovariectomy: effect of hormone replacement therapy. De Leo, V., Lanzetta, D., D'Antona, D., Danero, S. Fertil. Steril. (1993) [Pubmed]
  27. Effect of estrogen replacement therapy on hepatic triglyceride lipase, lipoprotein lipase and lipids including apolipoprotein E in climacteric and elderly women. Urabe, M., Yamamoto, T., Kashiwagi, T., Okubo, T., Tsuchiya, H., Iwasa, K., Kikuchi, N., Yokota, K., Hosokawa, K., Honjo, H. Endocr. J. (1996) [Pubmed]
  28. Effects of progestin-opposed transdermal estrogen administration on growth hormone and insulin-like growth factor-I in postmenopausal women of different ages. Bellantoni, M.F., Harman, S.M., Cho, D.E., Blackman, M.R. J. Clin. Endocrinol. Metab. (1991) [Pubmed]
  29. Oral dehydroepiandrosterone supplementation modulates spontaneous and growth hormone-releasing hormone-induced growth hormone and insulin-like growth factor-1 secretion in early and late postmenopausal women. Genazzani, A.D., Stomati, M., Strucchi, C., Puccetti, S., Luisi, S., Genazzani, A.R. Fertil. Steril. (2001) [Pubmed]
  30. Monitoring estrogen replacement therapy and identifying rapid bone losers with an immunoassay for deoxypyridinoline. Hesley, R.P., Shepard, K.A., Jenkins, D.K., Riggs, B.L. Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA. (1998) [Pubmed]
  31. Estrogen replacement therapy and antidepressant response to sertraline in older depressed women. Schneider, L.S., Small, G.W., Clary, C.M. The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry. (2001) [Pubmed]
  32. Progesterone involvement in breast development and tumorigenesis--as revealed by progesterone receptor "knockout" and "knockin" mouse models. Ismail, P.M., Amato, P., Soyal, S.M., DeMayo, F.J., Conneely, O.M., O'Malley, B.W., Lydon, J.P. Steroids (2003) [Pubmed]
  33. Caliper-measured skin thickness is similar in white and black women. Whitmore, S.E., Sago, N.J. J. Am. Acad. Dermatol. (2000) [Pubmed]
  34. Ovarian and adrenal steroid production: regulatory role of LH/HCG. Piltonen, T., Koivunen, R., Morin-Papunen, L., Ruokonen, A., Huhtaniemi, I.T., Tapanainen, J.S. Hum. Reprod. (2002) [Pubmed]
WikiGenes - Universities